Rheumatic patients in the intensive care unit

被引：0

作者：

Lehmann, P. ^{[1
,2
]}

Bruennler, T. ^{[2
]}

Salzberger, B. ^{[2
]}

Fleck, M. ^{[1
,2
]}

机构：

[1] Asklepios Klinikum Bad Abbach, Klin Rheumatol Klin Immunol, D-93077 Bad Abbach, Germany

[2] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 1, Regensburg, Germany

来源：

MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2012年 / 107卷 / 05期

关键词：

Autoimmune diseases; Intensive care units; Treatment outcome; Disease exacerbation; Infectious disease; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTITUMOR NECROSIS FACTOR; PROGNOSTIC-FACTORS; CRITICAL ILLNESS; INFECTIONS; ARTHRITIS; THERAPY; RISK; METAANALYSIS; ANTIBODY;

D O I：

10.1007/s00063-011-0073-y

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The mortality of patients with rheumatic diseases in the intensive care unit is generally high despite their relatively young age. In these patients, it is often difficult to make the diagnosis of the underlying autoimmune disease or to differentiate between septic complications and an acute flare; likewise, the complexity of the specific antirheumatic therapy can also be accompanied by problems. The following article gives an overview of problems in the diagnosis and treatment of critically ill patients with autoimmune diseases in the intensive care unit.

引用

页码：391 / 396

页数：6

共 50 条

[41] Survival in solid cancer patients following intensive care unit admission
Puxty, Kathryn
McLoone, Philip
Quasim, Tara
Kinsella, John
Morrison, David
INTENSIVE CARE MEDICINE, 2014, 40 (10) : 1409 - 1428
[42] The role of thyroid hormones in assessing the survival of intensive care unit patients
Bartolovic, Daniela
Jovicic, Snezana
Terzic, Branka
VOJNOSANITETSKI PREGLED, 2024, 81 (05) : 318 - 325
[43] Outcomes and nursing workload related to obese patients in the intensive care unit
Angotti Carrara, Fernanda Souza
Viski Zanei, Suely Sueko
Cremasco, Mariana Fernandes
Whitaker, Iveth Yamaguchi
INTENSIVE AND CRITICAL CARE NURSING, 2016, 35 : 45 - 51
[44] Opioids and Infections in the Intensive Care Unit Should Clinicians and Patients be Concerned?
Weinert, Craig R.
Kethireddy, Shravan
Roy, Sabita
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2008, 3 (04) : 218 - 229
[45] Critical Illness Neuromyopathy and Muscle Weakness in Patients in the Intensive Care Unit
Fan, Eddy
Zanni, Jennifer M.
Dennison, Cheryl R.
Lepre, Scott J.
Needham, Dale M.
AACN ADVANCED CRITICAL CARE, 2009, 20 (03) : 243 - 253
[46] Prevention of Delirium in the Intensive Care Unit
Braune, Stephan
Gurlit, Simone
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1611 - 1618
[47] Outcomes of patients admitted to the intensive care Unit after Postanesthesia care Unit boarding
Kiekkas, Panagiotis
Gklava, Vasso
Bellou, Aggeliki
Fligou, Fotini
Tzenalis, Anastasios
Igoumenidis, Michael
Aretha, Diamanto
AUSTRALIAN JOURNAL OF ADVANCED NURSING, 2024, 41 (04) : 14 - 21
[48] Systemic lupus erythematosus in the intensive care unit: a systematic review
Suarez-Avellaneda, Ana
Quintana, Jhon H.
Aragon, Cristian C.
Gallego, Linda M.
Gallego, Cindy-Natalia
Bolanos, Juan D.
Guerra, Maria A.
Ochoa, Maria Elena
Granados, Marcela
Ruiz-Ordonez, Ingrid
Tobon, Gabriel J.
LUPUS, 2020, 29 (11) : 1364 - 1376
[49] Iatrogenic Toxicities in the Intensive Care Unit
Nazer, Lama H.
Brown, Anne Rain T.
Awad, Wedad
CRITICAL CARE CLINICS, 2021, 37 (03) : 625 - 641
[50] A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality
Siripaitoon, B.
Lertwises, S.
Uea-areewongsa, P.
Khwannimit, B.
LUPUS, 2015, 24 (01) : 98 - 106

← 1 2 3 4 5 →